XML 94 R49.htm IDEA: XBRL DOCUMENT
v3.24.0.1

ACQUISITIONS AND DIVESTITURES - Business Acquisitions, Narrative (Details) |  |  | 1 Months Ended |  |
--- | --- | --- | --- | --- | ---
Dec. 06, 2022 USD ($) | Dec. 06, 2022 USD ($) payment | Dec. 06, 2022 USD ($) contingentLiability | Jan. 20, 2021 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Jun. 30, 2021 USD ($)
Surgical Innovation Association Inc |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Payments to acquire business | $ 51,500,000 |  |  |  |  |  |
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) | $ 90,000,000 | $ 90,000,000 | $ 90,000,000 |  |  |  |
Business Acquisition, number of payments |  | 2 | 2 |  |  |  |
Discount rate | 18.00% | 18.00% | 18.00% |  |  |  |
Contingent consideration | $ 57,607,000 | $ 57,607,000 | $ 57,607,000 |  |  |  |
Surgical Innovation Association Inc | Revenue Based Performance Milestones |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) | 50,000,000 | 50,000,000 | 50,000,000 |  |  |  |
Contingent consideration, cash payments due upon achievement of certain milestones | 32,600,000 | 32,600,000 | 32,600,000 |  | $ 41,800,000 |  |
Surgical Innovation Association Inc | FDA Approval Of Premarket Approval |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) | 40,000,000 | 40,000,000 | 40,000,000 |  |  |  |
Contingent consideration, cash payments due upon achievement of certain milestones | $ 25,000,000 | $ 25,000,000 | $ 25,000,000 |  | 26,900,000 |  |
Acclarent, Inc. |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Contingent consideration, cash payments due upon achievement of certain milestones |  |  |  |  | 5,000,000 |  |
Purchase price of business acquisition |  |  |  |  | 275,000,000 |  |
ACell, Inc. |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Payments to acquire business |  |  |  | $ 306,900,000 |  |  |
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) |  |  |  | $ 100,000,000 |  |  |
Discount rate |  |  |  | 8.50% |  |  |
Working capital adjustment |  |  |  |  |  |  | $ 1,300,000
Contingent consideration |  |  |  | $ 23,900,000 | $ 300,000 | $ 3,700,000 |
ACell, Inc. | Revenue-Based Performance Milestones In 2023 |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) |  |  |  | 50,000,000 |  |  |
ACell, Inc. | Revenue Based Performance Milestones In 2025 |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) |  |  |  | $ 50,000,000 |  |  |

X
- Definition Business Acquisition, Number Of Contingent Liabilities + References No definition available. + Details
Name: | iart_BusinessAcquisitionNumberOfContingentLiabilities
Namespace Prefix: | iart_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Intangible Asset Acquired, Discount Rate + References No definition available. + Details
Name: | iart_BusinessCombinationIntangibleAssetAcquiredDiscountRate
Namespace Prefix: | iart_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Combination, Working Capital Adjustment + References No definition available. + Details
Name: | iart_BusinessCombinationWorkingCapitalAdjustment
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 8 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 7 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 35 -Paragraph 1 -Subparagraph (b) -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_SurgicalInnovationAssociatesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=iart_RevenueBasedPerformanceMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=iart_FDAApprovalOfPremarketApprovalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_AcclarentInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_ACellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=iart_RevenueBasedPerformanceMilestonesIn2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=iart_RevenueBasedPerformanceMilestonesIn2025Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |